Press Release

Mounting Investments in Healthcare Infrastructure across the Middle East & Africa to Drive Antimicrobial Coatings Market through 2026

The Middle East & Africa Antimicrobial Coatings Market is expected to observe around 8% CAGR during 2021-26, says MarkNtel Advisors in their research report. The market growth attributes primarily to the mounting adoption of antimicrobial coatings across several industries in the Middle East & Africa, owing to the rising awareness among people regarding safety & hygiene. The burgeoning demand for antimicrobial coatings from the healthcare sector has minimized the probability of healthcare-associated infections (HCAI) since they can be well-used in clinical items & surfaces.

Moreover, the growing awareness regarding antimicrobial-coated packaging that helps reduce the chances of microbial contamination in packaged food boosts the market. In addition, increasing concerns regarding air quality, coupled with the surging demand for HVAC systems, are other crucial aspects projected to drive the market in the coming years, further states the research report, “Middle East & Africa Antimicrobial Coatings Market Analysis, 2021.” 

Key questions answered in the study

1. What are the current & future trends in the Middle East & Africa Antimicrobial Coatings Market?
2. How has the industry been evolving in terms of geography & services adoption?
3. How has the competition been shaping across the Middle East & Africa, followed by their comparative factorial indexing?
4. What are the key growth drivers & challenges for the Middle East & Africa Antimicrobial Coatings Market?
5. What are the customer orientation, purchase behavior, and expectations from antimicrobial coating manufacturers across the Middle East & Africa?

Medical & Healthcare Sector Captures the Largest Market

In the medical & healthcare sector, antimicrobial coatings are used in medical devices & surfaces to prevent infections from spreading. After the Covid-19 pandemic in 2020, the need for various healthcare infrastructure developments has increased substantially, which, in turn, has equally surged the demand for antimicrobial coatings on walls, surfaces, & medical devices. Hence, the rapid expansion of healthcare facilities across the Middle East & Africa region is projected to accelerate the overall market growth during 2021-26.

With Massive Investments in Healthcare Infrastructure, Saudi Arabia Acquired the Largest Market Share

Saudi Arabia is witnessing rapid expansions in its healthcare sector, especially after the Covid-19 pandemic. The country is planning to invest around $66 billion in its healthcare infrastructure by 2030 and influence more private companies to participate in the sector. These developments in healthcare infrastructure shall boost the production & sales of antimicrobial coatings.

The Covid-19 pandemic has also positively influenced the demand for antimicrobial coatings, mainly due to the burgeoning concerns regarding prevention against infection. Further, the increasing need for HVAC products & transport vehicles is another crucial aspect fueling the adoption of antimicrobial coatings across Saudi Arabia, reveals MarkNtel Advisors in their research report, “Middle East & Africa Antimicrobial Coatings Market Analysis, 2021.”

According to MarkNtel Advisors, the leading players in the Middle East & Africa Antimicrobial Coatings Market are AkzoNobel, Nippon Paint, Dow Chemical, BASF SE, Lonza Group, Axalta Coating Systems, Diamond Vogel, Sherwin-Williams, RPM International Inc., and Royal DSM.

Market Segmentation:

1. By Type (Silver, Copper, Titanium Oxide, Others (Zinc, Quaternary Ammonium Biocides, etc.))
2. By Application(Medical & Healthcare, HVAC System, Building & Construction, Textile, Food & Beverage, Others (Transportation, Home Appliance, etc.))
3. By Country (Saudi Arabia, UAE, Qatar, Oman, South Africa, Nigeria, Algeria, Morocco, Others)
4. By Competitors (AkzoNobel, Nippon Paint Dow Chemical, BASF SE, Lonza Group, Axalta Coating Systems, Diamond Vogel, Sherwin-Williams, RPM International Inc., Royal DSM)